A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing

Published:2018-05 Issue: Volume:133 Page:28-38
ISSN:1369-703X
Container-title:Biochemical Engineering Journal
language:en
Short-container-title:Biochemical Engineering Journal

Author:

Glen Katie E.,Cheeseman Elizabeth A.,Stacey Adrian J.,Thomas Robert J.

Funder

Engineering and Physical Sciences Research Council Fellowship

Wellcome Trust Translational Fund

Publisher

Elsevier BV

Subject

Biomedical Engineering,Environmental Engineering,Bioengineering,Biotechnology

Reference23 articles.

1. Advanced therapy medicinal products: current and future perspectives;Hanna;J. Mark. Access Health Policy,2016

2. Nonclinical safety strategies for stem cell therapies;Sharpe;Toxicol. Appl. Pharmacol.,2012

3. Origins and implications of pluripotent stem cell variability and heterogeneity;Cahan;Nat. Rev. Mol. Cell Biol.,2013

4. Predictions for optimal mitigation of paracrine inhibitory signalling in haemopoietic stem cell cultures;Berry;Stem Cell Res. Ther.,2015

5. Systematic optimization of human pluripotent stem cells media using design of experiments;Marinho;Sci. Rep.,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production and stability of cultured red blood cells depends on the concentration of cholesterol in culture medium;Scientific Reports;2024-07-06

2. Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control;Cytotherapy;2024-04

3. Structural and practical identifiability analysis in bioengineering: a beginner’s guide;Journal of Biological Engineering;2024-03-04

4. Stochastic simulation uncertainty analysis to accelerate flexible biomanufacturing process development;European Journal of Operational Research;2023-10

5. Advances in bioreactor control for production of biotherapeutic products;Biotechnology and Bioengineering;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3